Skip to main content

Table 1 Effect of therapy on metastatic burden in mice bearing Pan02 tumors

From: The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer

  Number Incidence (%)
Control 14 6/8 (75)
CT 0 0/8 (0)
GEM 0 0/8 (0)
CT+ GEM 0 0/10 (0)
  1. Metastatic events in mice bearing orthotopic Pan02 tumors were evaluated by visual inspection of the liver, lungs, and entire gastrointestinal tract at the time of sacrifice.